Literature DB >> 25717245

Endocytoscopic narrow-band imaging efficiency for evaluation of inflammatory activity in ulcerative colitis.

Yasuharu Maeda1, Kazuo Ohtsuka1, Shin-ei Kudo1, Kunihiko Wakamura1, Yuichi Mori1, Noriyuki Ogata1, Yoshiki Wada1, Masashi Misawa1, Akihiro Yamauchi1, Seiko Hayashi1, Toyoki Kudo1, Takemasa Hayashi1, Hideyuki Miyachi1, Fuyuhiko Yamamura1, Fumio Ishida1, Haruhiro Inoue1, Shigeharu Hamatani1.   

Abstract

AIM: To assess the efficacy of endocytoscopic narrow-band imaging (EC-NBI) for evaluating the severity of inflammation in ulcerative colitis (UC).
METHODS: This retrospective study was conducted at a single tertiary care referral center. We included UC patients who underwent colonoscopy with endocytoscopy from July 2010 to December 2013. EC-NBI was performed, and the images were evaluated by assessing visibility, increased vascularization, and the increased calibers of capillaries and were classified as Obscure, Visible or Dilated. Obscure was indicative of inactive disease, while Visible and Dilated were indicative of acute inflammation. This study received Institutional Review Board approval. The primary outcome measures included the diagnostic ability of EC-NBI to distinguish between active and inactive UC on the basis of histological activity. The conventional endoscopic images were classified according to the Mayo endoscopic score. A score of 0 or 1 indicated inactive disease, whereas a score of 2 indicated active disease.
RESULTS: Fifty-two patients were enrolled. There was a strong correlation between the EC-NBI findings and the histological assessment (r=0.871, P<0.01). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of EC-NBI for diagnosing acute inflammation were 84.0%, 100%, 87.1%, 100%, and 92.3%, respectively, while those for the Mayo endoscopic score were 100%, 40.7%, 100%, 61.0%, and 69.2%, respectively. Compared with conventional endoscopy, EC-NBI was superior in diagnostic specificity, negative predictive value, and accuracy (P<0.001, P=0.001 and P=0.047, respectively).
CONCLUSION: The EC-NBI finding of capillaries in the rectal mucosa was strongly correlated with histological inflammation and aided in the differential diagnosis between active and inactive UC.

Entities:  

Keywords:  Endosytoscopy; Histological healing; Magnified endoscopy; Mucosal healing; Narrow-band imaging; Ulcerative colitis

Mesh:

Year:  2015        PMID: 25717245      PMCID: PMC4326147          DOI: 10.3748/wjg.v21.i7.2108

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Diagnosis of colorectal lesions with a novel endocytoscopic classification - a pilot study.

Authors:  S-E Kudo; K Wakamura; N Ikehara; Y Mori; H Inoue; S Hamatani
Journal:  Endoscopy       Date:  2011-08-11       Impact factor: 10.093

2.  Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy.

Authors:  Chang-Qing Li; Xiang-Jun Xie; Tao Yu; Xiao-Meng Gu; Xiu-Li Zuo; Cheng-Jun Zhou; Wei-Qing Huang; Hua Chen; Yan-Qing Li
Journal:  Am J Gastroenterol       Date:  2009-11-24       Impact factor: 10.864

Review 3.  Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis.

Authors:  Motohiro Esaki; Naoya Kubokura; Tetsuji Kudo; Takayuki Matsumoto
Journal:  Dig Endosc       Date:  2011-05       Impact factor: 7.559

Review 4.  Review article: in vivo imaging by endocytoscopy.

Authors:  H Neumann; F S Fuchs; M Vieth; R Atreya; J Siebler; R Kiesslich; M F Neurath
Journal:  Aliment Pharmacol Ther       Date:  2011-04-04       Impact factor: 8.171

5.  In vivo assessment of a carcinoid tumor using endocytoscopy.

Authors:  Yasuharu Maeda; Shin-Ei Kudo; Yuichi Mori
Journal:  Dig Endosc       Date:  2013-04-07       Impact factor: 7.559

6.  Efficiency of endocytoscopy in differentiating types of serrated polyps.

Authors:  Makoto Kutsukawa; Shin-Ei Kudo; Nobunao Ikehara; Yushi Ogawa; Kunihiko Wakamura; Yuichi Mori; Katsuro Ichimasa; Masashi Misawa; Toyoki Kudo; Yoshiki Wada; Takemasa Hayashi; Hideyuki Miyachi; Haruhiro Inoue; Shigeharu Hamatani
Journal:  Gastrointest Endosc       Date:  2013-10-08       Impact factor: 9.427

7.  Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.

Authors:  Talat Bessissow; Bart Lemmens; Marc Ferrante; Raf Bisschops; Kristel Van Steen; Karel Geboes; Gert Van Assche; Séverine Vermeire; Paul Rutgeerts; Gert De Hertogh
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

8.  Correlation between endocytoscopy and conventional histopathology in microstructural features of ulcerative colitis.

Authors:  Rieko Bessho; Takanori Kanai; Naoki Hosoe; Taku Kobayashi; Tetsuro Takayama; Nagamu Inoue; Makio Mukai; Haruhiko Ogata; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2011-07-30       Impact factor: 7.527

Review 9.  Treat the patient or treat the disease?

Authors:  Stephen B Hanauer; Joseph B Kirsner
Journal:  Dig Dis       Date:  2012-07-12       Impact factor: 2.404

10.  In vivo real-time imaging of human duodenal mucosal structures in celiac disease using endocytoscopy.

Authors:  T Matysiak-Budnik; E Coron; J-F Mosnier; M Le Rhun; H Inoue; J-P Galmiche
Journal:  Endoscopy       Date:  2010-01-25       Impact factor: 10.093

View more
  8 in total

1.  Accuracy of computer-aided diagnosis based on narrow-band imaging endocytoscopy for diagnosing colorectal lesions: comparison with experts.

Authors:  Masashi Misawa; Shin-Ei Kudo; Yuichi Mori; Kenichi Takeda; Yasuharu Maeda; Shinichi Kataoka; Hiroki Nakamura; Toyoki Kudo; Kunihiko Wakamura; Takemasa Hayashi; Atsushi Katagiri; Toshiyuki Baba; Fumio Ishida; Haruhiro Inoue; Yukitaka Nimura; Msahiro Oda; Kensaku Mori
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-02-28       Impact factor: 2.924

Review 2.  Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?

Authors:  Noor Mohammed; Venkataraman Subramanian
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

3.  Role of new endoscopic techniques in inflammatory bowel disease management: Has the change come?

Authors:  Loredana Goran; Lucian Negreanu; Ana Maria Negreanu
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

4.  Narrow-Band Imaging Colonoscopy to Assess Mucosal Angiogenesis in Ulcerative Colitis.

Authors:  Tao Guo; Jia-Ming Qian; Ai-Ming Yang; Yue Li; Wei-Xun Zhou
Journal:  Gastroenterol Res Pract       Date:  2019-02-24       Impact factor: 2.260

5.  A novel endoscopic imaging system for quantitative evaluation of colonic mucosal inflammation in patients with quiescent ulcerative colitis.

Authors:  Yusuke Honzawa; Minoru Matsuura; Hirokazu Higuchi; Takaki Sakurai; Hiroshi Seno; Hiroshi Nakase
Journal:  Endosc Int Open       Date:  2020-01-08

6.  Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis.

Authors:  Seiko Sasanuma; Kazuo Ohtsuka; Shin-Ei Kudo; Noriyuki Ogata; Yasuharu Maeda; Masashi Misawa; Yuichi Mori; Toyoki Kudo; Tomokauzu Hisayuki; Kunihiko Wakamura; Takemasa Hayashi; Atsushi Katagiri; Hideyuki Miyachi; Toshiyuki Baba; Fumio Ishida
Journal:  Endosc Int Open       Date:  2018-04-18

7.  Significance of Linked Color Imaging for Predicting the Risk of Clinical Relapse in Ulcerative Colitis.

Authors:  Shuji Kanmura; Akihito Tanaka; Kazuki Yutsudou; Kosuke Kuwazuru; Fukiko Komaki; Yuga Komaki; Hiromichi Iwaya; Shiho Arima; Fumisato Sasaki; Shiroh Tanoue; Shinichi Hashimoto; Akio Ido
Journal:  Gastroenterol Res Pract       Date:  2020-03-06       Impact factor: 2.260

8.  Correlation of minimally invasive imaging techniques to assess intestinal mucosal perfusion with established markers of chronic inflammatory enteropathy in dogs.

Authors:  Mazdak Salavati; Jorge Pérez-Accino; Yi Lin Tan; Tiziana Liuti; Sionagh Smith; Linda Morrison; Silke Salavati Schmitz
Journal:  J Vet Intern Med       Date:  2020-12-12       Impact factor: 3.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.